Nonetheless, we were able to confirm upregulated expression of LAT1 following chronic ADT at both protein and mRNA levels, while ASCT2 (SLC1A5) expression was at low level in 22Rv1 CRPC tumours under chronic ADT. The gene discussed is SLC7A5; the disease is neoplasm.